Investigation of two suspected diarrhoeal-illness outbreaks in Northern Cape and KwaZulu-Natal provinces, South Africa, April-July 2013: The role of rotavirus.

South Africa diarrhoeal illness outbreak rotavirus rotavirus vaccine

Journal

Southern African journal of infectious diseases
ISSN: 2313-1810
Titre abrégé: S Afr J Infect Dis
Pays: South Africa
ID NLM: 101646666

Informations de publication

Date de publication:
2020
Historique:
received: 31 05 2019
accepted: 22 04 2020
entrez: 6 9 2021
pubmed: 22 7 2020
medline: 22 7 2020
Statut: epublish

Résumé

Suspected diarrhoeal-illness outbreaks affecting mostly children < 5 years were investigated between May and July 2013 in Northern Cape province (NCP) and KwaZulu-Natal (KZN) province. This study describes the epidemiological, environmental and clinical characteristics and diarrhoeal-illnesses causative agent(s). A descriptive cross-sectional study was conducted. Cases were patients presenting at healthcare facilities with diarrhoeal-illness between 09 April and 09 July 2013 in NCP and 01 May and 31 July 2013 in KZN. Laboratory investigations were performed on stools and water samples using microscopy, culture and sensitivity screening and molecular assays. A total of 953 cases including six deaths (case fatality rate [CFR]: 0.6%) were recorded in the Northern Cape province outbreak. Children < 5 years accounted for 58% of cases. Enteric viruses were detected in 51% of stools, with rotavirus detected in 43%. The predominant rotavirus strains were G3P[8] (45%) and G9P[8] (42%). Other enteric viruses were detected, with rotavirus co-infections (63%). No enteric pathogens detected in water specimens. Although source(s) of the outbreaks were not identified, the diarrhoeal-illnesses were community-acquired. It is difficult to attribute the outbreaks to one causative agent(s) because of rotavirus co-infections with other enteric pathogens. While rotavirus was predominant, the outbreaks coincided with the annual rotavirus season.

Sections du résumé

BACKGROUND BACKGROUND
Suspected diarrhoeal-illness outbreaks affecting mostly children < 5 years were investigated between May and July 2013 in Northern Cape province (NCP) and KwaZulu-Natal (KZN) province. This study describes the epidemiological, environmental and clinical characteristics and diarrhoeal-illnesses causative agent(s).
METHODS METHODS
A descriptive cross-sectional study was conducted. Cases were patients presenting at healthcare facilities with diarrhoeal-illness between 09 April and 09 July 2013 in NCP and 01 May and 31 July 2013 in KZN. Laboratory investigations were performed on stools and water samples using microscopy, culture and sensitivity screening and molecular assays.
RESULTS RESULTS
A total of 953 cases including six deaths (case fatality rate [CFR]: 0.6%) were recorded in the Northern Cape province outbreak. Children < 5 years accounted for 58% of cases. Enteric viruses were detected in 51% of stools, with rotavirus detected in 43%. The predominant rotavirus strains were G3P[8] (45%) and G9P[8] (42%). Other enteric viruses were detected, with rotavirus co-infections (63%). No enteric pathogens detected in water specimens.
CONCLUSION CONCLUSIONS
Although source(s) of the outbreaks were not identified, the diarrhoeal-illnesses were community-acquired. It is difficult to attribute the outbreaks to one causative agent(s) because of rotavirus co-infections with other enteric pathogens. While rotavirus was predominant, the outbreaks coincided with the annual rotavirus season.

Identifiants

pubmed: 34485475
doi: 10.4102/sajid.v35i1.159
pii: SAJID-35-159
pmc: PMC8378150
doi:

Types de publication

Journal Article

Langues

eng

Pagination

159

Informations de copyright

© 2020. The Authors.

Déclaration de conflit d'intérêts

The authors have declared that no competing interest exists.

Références

Vaccine. 2012 Sep 7;30 Suppl 3:C14-20
pubmed: 22939015
Clin Infect Dis. 2016 May 1;62 Suppl 2:S96-S105
pubmed: 27059362
Science. 2009 Jul 17;325(5938):290-4
pubmed: 19608910
Curr Opin Virol. 2012 Aug;2(4):434-42
pubmed: 22749491
Clin Infect Dis. 2016 May 1;62 Suppl 2:S188-95
pubmed: 27059355
Mol Biol Evol. 2011 Oct;28(10):2731-9
pubmed: 21546353
Dtsch Arztebl Int. 2009 Aug;106(33):539-47; quiz 548
pubmed: 19738921
N Engl J Med. 2011 Sep 22;365(12):1108-17
pubmed: 21992123
Lancet Glob Health. 2015 Sep;3(9):e564-75
pubmed: 26202075
Pediatr Infect Dis J. 2013 Apr;32(4):e134-47
pubmed: 23190782
Lancet Infect Dis. 2012 Feb;12(2):136-41
pubmed: 22030330
Nutr J. 2011 Oct 11;10:110
pubmed: 21989455
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Lancet. 2012 Jun 9;379(9832):2151-61
pubmed: 22579125
Emerg Infect Dis. 2010 Aug;16(8):1303-5
pubmed: 20678331
Mol Biol Evol. 1992 Jul;9(4):678-87
pubmed: 1630306
N Engl J Med. 2010 Jan 28;362(4):289-98
pubmed: 20107214
Lancet. 2007 Nov 24;370(9601):1757-63
pubmed: 18037080
Vaccine. 2010 Sep 7;28(39):6542-8
pubmed: 18786585
PLoS One. 2012;7(8):e41720
pubmed: 22879893
Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
N Engl J Med. 2006 Jan 5;354(1):11-22
pubmed: 16394298
J Infect Dis. 2010 Sep 1;202 Suppl:S131-8
pubmed: 20684693
Infect Dis Clin North Am. 2015 Dec;29(4):617-35
pubmed: 26337738
J Infect Dis. 2010 Sep 1;202 Suppl:S5-S11
pubmed: 20684718
Lancet Infect Dis. 2014 Nov;14(11):1096-1104
pubmed: 25303843
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Clin Microbiol Infect. 2003 Apr;9(4):247-62
pubmed: 12667234
Vaccine. 2003 Jan 17;21(5-6):354-60
pubmed: 12531632
Pan Afr Med J. 2011;8:47
pubmed: 22121455
J Clin Microbiol. 1986 May;23(5):992-4
pubmed: 3711291
PLoS One. 2012;7(1):e29151
pubmed: 22235266
Lancet Glob Health. 2016 Jan;4(1):e25
pubmed: 26718806
Expert Rev Vaccines. 2009 Dec;8(12):1627-41
pubmed: 19943758
Int J Environ Res Public Health. 2012 Mar;9(3):895-915
pubmed: 22690171
Lancet Glob Health. 2015 Sep;3(9):e510-1
pubmed: 26202076
Evolution. 1985 Jul;39(4):783-791
pubmed: 28561359
J Med Microbiol. 2015 Apr;64(Pt 4):432-437
pubmed: 25713206
Emerg Infect Dis. 2006 Feb;12(2):304-6
pubmed: 16494759
Epidemiol Infect. 2018 Jul;146(10):1318-1325
pubmed: 29781418
Pediatr Infect Dis J. 2013 Dec;32(12):1359-64
pubmed: 24569308
Pediatr Infect Dis J. 2011 Feb;30(2):125-30
pubmed: 20842070
Niger J Clin Pract. 2011 Apr-Jun;14(2):237-41
pubmed: 21860147

Auteurs

Andronica M Shonhiwa (AM)

Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, National Health Laboratory Service, Sandringham, Johannesburg, South Africa.

Genevie Ntshoe (G)

Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, National Health Laboratory Service, Sandringham, Johannesburg, South Africa.
School of Health Systems and Public Health, Faculty of Health Science, University of Pretoria, Pretoria, South Africa.

Noreen Crisp (N)

Communicable Disease Control, Department of Health, Kimberley, South Africa.

Ayo J Olowolagba (AJ)

Communicable Disease Control, eThekwini Metropolitan Municipality Department of Health, Durban, South Africa.

Vusi Mbuthu (V)

Communicable Disease Control, eThekwini Metropolitan Municipality Department of Health, Durban, South Africa.

Maureen B Taylor (MB)

School of Health Systems and Public Health, Faculty of Health Science, University of Pretoria, Pretoria, South Africa.
Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
National Health Laboratory Service, Tshwane Academic Division, Pretoria, South Africa.

Juno Thomas (J)

Centre for Enteric Diseases, National Institute for Communicable Diseases, National Health Laboratory Service, Sandringham, Johannesburg, South Africa.

Nicole A Page (NA)

Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Centre for Enteric Diseases, National Institute for Communicable Diseases, National Health Laboratory Service, Sandringham, Johannesburg, South Africa.

Classifications MeSH